Nexentis Technologies Inc. (NXTS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nexentis Technologies Inc. (NXTS) has a cash flow conversion efficiency ratio of -0.110x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.42 Million) by net assets ($12.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review Nexentis Technologies Inc. financial flexibility index to assess the company's free cash flow relative to its total liabilities.
Nexentis Technologies Inc. - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Nexentis Technologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Nexentis Technologies Inc. stock valuation for the company's overall valuation and market capitalisation.
Nexentis Technologies Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nexentis Technologies Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Datadot Technology Ltd
AU:DDT
|
-0.008x |
|
Arkha Jayanti Persada PT
JK:ARKA
|
0.000x |
|
Laxmi Cotspin Limited
NSE:LAXMICOT
|
0.025x |
|
Dialight plc
LSE:DIA
|
0.300x |
|
SRT Marine Systems plc
LSE:SRT
|
-0.305x |
|
1844 Resources Inc
V:EFF
|
0.136x |
|
NT Minerals Ltd
AU:NTM
|
-0.063x |
|
Galore Resources Inc
V:GRI
|
-0.017x |
Annual Cash Flow Conversion Efficiency for Nexentis Technologies Inc. (2009–2025)
The table below shows the annual cash flow conversion efficiency of Nexentis Technologies Inc. from 2009 to 2025. View Nexentis Technologies Inc. share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $15.73 Million | $-3.81 Million | -0.242x | +67.62% |
| 2024-12-31 | $4.57 Million | $-3.42 Million | -0.748x | -49.37% |
| 2023-12-31 | $6.46 Million | $-3.23 Million | -0.501x | +43.66% |
| 2022-12-31 | $5.74 Million | $-5.10 Million | -0.888x | -39.01% |
| 2021-12-31 | $6.41 Million | $-4.10 Million | -0.639x | -137.24% |
| 2020-12-31 | $-465.45K | $-798.74K | 1.716x | -44.56% |
| 2019-12-31 | $-402.12K | $-1.24 Million | 3.096x | +229.27% |
| 2018-12-31 | $211.51K | $-506.50K | -2.395x | -381.37% |
| 2017-12-31 | $-732.29K | $-623.23K | 0.851x | +9.49% |
| 2016-12-31 | $-837.46K | $-650.99K | 0.777x | +348.81% |
| 2013-12-31 | $-746.71K | $-129.33K | 0.173x | -71.63% |
| 2012-12-31 | $-886.20K | $-540.99K | 0.610x | -78.45% |
| 2011-12-31 | $-233.01K | $-660.17K | 2.833x | +175.09% |
| 2010-12-31 | $-418.36K | $-430.89K | 1.030x | -68.82% |
| 2009-12-31 | $-256.64K | $-847.77K | 3.303x | -- |
About Nexentis Technologies Inc.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model… Read more